123 related articles for article (PubMed ID: 18486757)
1. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis.
Fernández-Morera JL; Rodríguez-Rodero S; Lahoz C; Tuñon A; Astudillo A; Garcia-Suarez O; Martínez-Borra J; López-Vázquez A; Rodrigo L; Gonzalez S; López-Larrea C
Hum Immunol; 2008; 69(4-5):235-40. PubMed ID: 18486757
[TBL] [Abstract][Full Text] [Related]
2. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
[TBL] [Abstract][Full Text] [Related]
3. Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma.
Tamaki S; Kawakami M; Ishitani A; Kawashima W; Kasuda S; Yamanaka Y; Shimomura H; Imai Y; Nakagawa Y; Hatake K; Kirita T
Anticancer Res; 2010 Oct; 30(10):4097-101. PubMed ID: 21036725
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
[TBL] [Abstract][Full Text] [Related]
5. Monocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8/14 levels.
Floris S; van der Goes A; Killestein J; Knol DL; Barkhof F; Polman CH; Dijkstra CD; de Vries HE; Meilof JF
J Neuroimmunol; 2004 Mar; 148(1-2):172-7. PubMed ID: 14975598
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
[TBL] [Abstract][Full Text] [Related]
7. Prevalent expression of MHC class I chain-related molecule A in human osteosarcoma.
Lu SM; Xiao P; Xue L; Che LH; Yang P; Li Y; Qiao H
Neoplasma; 2008; 55(3):266-72. PubMed ID: 18348660
[TBL] [Abstract][Full Text] [Related]
8. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.
Vogt MH; Floris S; Killestein J; Knol DL; Smits M; Barkhof F; Polman CH; Nagelkerken L
J Neuroimmunol; 2004 Oct; 155(1-2):155-60. PubMed ID: 15342207
[TBL] [Abstract][Full Text] [Related]
10. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.
Bilińska M; Frydecka I; Podemski R; Gruszka E
Med Sci Monit; 2002 Oct; 8(10):CR720-3. PubMed ID: 12388926
[TBL] [Abstract][Full Text] [Related]
12. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.
Tamaki S; Sanefuzi N; Kawakami M; Aoki K; Imai Y; Yamanaka Y; Yamamoto K; Ishitani A; Hatake K; Kirita T
Hum Immunol; 2008 Feb; 69(2):88-93. PubMed ID: 18361932
[TBL] [Abstract][Full Text] [Related]
13. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
Quiroga I; Salio M; Koo DD; Cerundolo L; Shepherd D; Cerundolo V; Fuggle SV
Transplantation; 2006 Apr; 81(8):1196-203. PubMed ID: 16641608
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Caniatti ML; Baldi E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2007 Dec; 192(1-2):219-25. PubMed ID: 17997167
[TBL] [Abstract][Full Text] [Related]
16. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis.
Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Sfagos C
J Neuroendocrinol; 2010 Jun; 22(6):503-8. PubMed ID: 20236233
[TBL] [Abstract][Full Text] [Related]
17. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA
J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
[TBL] [Abstract][Full Text] [Related]
19. MICB gene expression on peripheral blood mononuclear cells and susceptibility to multiple sclerosis in north of Iran.
Abediankenari S; Yousefzadeh Y; Majidi M; Ghasemi M; Nasehi MM; Ghaffari J; Habibi Saravi R; Abedini M; Elyasi M
Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):261-5. PubMed ID: 22184268
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
